Matthew Callahan, Executive Director of Botanix Pharmaceuticals (ASX:BOT), discusses the company’s strategy following the US launch of Sofdra, a topical gel for hyperhidrosis. With dermatology products reaching peak revenue within three months, analysts project revenue between $15m and $20m this financial year, rising to $100m next year. Callahan highlights the company’s direct-to-patient platform, which enhances profitability by reducing distribution costs and ensuring patient adherence through automatic refills. Botanix remains focused on scaling Sofdra’s rollout while evaluating opportunities to leverage its platform for further expansion.
19 May 2023 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the significance of recent announcements on the back of a surge in trading volume.
28 Apr 2020 - BrainChip Holdings (ASX:BRN BrainChip Holdings (ASX:BRN) CEO Lou DiNardo talks about its Akida integrated circuit, its advantages in event-based convolutional (e-conv) networks, applications and its move to wafer production and first engineering samples by Q3 2020.
06 Nov 2024 - Paul Sanger interviewed Damian Spring, CEO of Santana Minerals Limited (ASX:SMI), to discuss the Bendigo gold project, which has recently been designated as a fast-track project.
07 Nov 2023 - Newly appointed Lincoln Minerals (ASX:LML) CEO Jonathon Trewartha discusses their focus on developing the Kookaburra Gully Graphite Project in South Australia. He highlights plans to expand the resource through drilling, aiming for a 10-year mine life, and addresses the company's response to global market changes impacting graphite production.
05 Sep 2024 - IVE Group Limited (ASX:IGL) Managing Director Matt Aitken discusses the company's activities over the past year, touching on key metrics and projects, costs, integration of Ovato, sustainability initiatives, acquisitions of JacPak and Elastic Group, and Lasoo's performance.
23 Sep 2020 - Shaw and Partners Chief Investment Officer Martin Crabb discusses signs of market recovery, government support, coronavirus vaccines and small cap performance.
01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
21 Oct 2024 - Ken Morrison, CEO of the Bradfield Development Authority, discusses building Australia's first new city in a century, a high-tech urban project linked to the new Western Sydney International Airport.
07 Sep 2022 - IVE Group (ASX:IGL) Executive Chairman Geoff Selig discusses full-year results, the recent acquisition of Ovato and the launch of the Lasoo e-commerce platform.
05 Dec 2019 - Bio-Gene Technology Limited (ASX:BGT) CEO, Richard Jagger discusses the company's novel suite of insecticides, progress with trials and market opportunity.
